Clinical observation and mechanism of buccal needle therapy in the treatment of novel coronavirus pneumonia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300070444

Enrollment

Unknown

Registered

2023-04-12

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus pneumonia

Interventions

Experimental group:Buccal acupuncture needle, in accordance with the principles of general treatment and treatment of severe and critical cases in the Diagnosis and Treatment Protocol of novel Coronav

Control group:In accordance with the principles of general treatment and treatment of severe and critical cases in the Diagnosis and Treatment Protocol of novel Coronavirus Pneumonia, patients should

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for common and severe COVID-19; 2. Aged >=18 years; 3. Informed consent of patients.

Exclusion criteria

Exclusion criteria: 1. Patients without access to complete diagnosis and treatment information; 2. Patients with unknown clinical outcome.

Design outcomes

Primary

Measure	Time frame
inflammatory factor;C-reactive protein;	—

Secondary

Measure	Time frame
hepatorenal function;white blood cells, neutrophils, lymphocytes, platelets;	—

Countries

China

Contacts

Public ContactZhong Wenhui

Shanghai Sixth People's Hospital

zwhdyl@163.com+86 18930174695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026